JESSICA TEETER: Open Payments
NPI 1003524216 · ENOLA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$494 in 26 payments from 11 companies in 2025. Trend: 2023 $575 · 2024 $309 · 2025 $494
Food & beverage: $494
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $102 |
| BridgeBio Pharma, Inc. | 5 | $96 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76 |
| ABIOMED | 2 | $68 |
| SCPHARMACEUTICALS INC. | 2 | $33 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| Chiesi USA, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| Novartis Pharmaceuticals Corporation | 1 | $16 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
Products named: Attruby, Wegovy, JARDIANCE, FUROSCIX, KENGREAL, REPATHA, Rybelsus, LEQVIO.
Industry payments across PA — which companies pay providers there.
